Medical Condition News

RSS

UMass Amherst and Brigham launch MassAITC to improve in-home care for Alzheimer's patients

The University of Massachusetts Amherst and Brigham and Women's Hospital announced today the launch of the new Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MassAITC), which seeks to improve in-home care for older adults and individuals with Alzheimer's disease, thanks to a grant from the National Institute on Aging (NIA), which is part of the National Institutes of Health.

1 Nov 2021

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.

1 Nov 2021

Platelet inhibitors may be linked with reduction in digital ulcers in people with systemic sclerosis

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of platelet inhibitors could be associated with a reduction in the occurrence of digital ulcers, painful sores on the extremities that can progress to gangrene, in people with systemic sclerosis.

1 Nov 2021

New findings can help identify people at increased risk of hydroxychloroquine-related retinopathy

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that higher doses, longer duration of use, chronic kidney disease and Asian race could all be independent risk factors for retinopathy in people using hydroxychloroquine, an antimalarial drug commonly used to treat lupus, rheumatoid arthritis and other diseases.

1 Nov 2021

Startup receives funding for developing a device to prevent epilepsy-related death

Neurava, a startup located in West Lafayette, Indiana, announced Monday (Nov. 1) that it has received more than $650,000 in seed funding led by Elevate Ventures with participation from Purdue Foundry, First Leaf Capital, UCB Biopharma, iO Life Ventures and angel investors.

1 Nov 2021

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

The magnitude of cross-reactive antibodies correlated well with responses to the SARS-CoV-2 spike protein and the S2 subdomain.

1 Nov 2021

Do weather and climate determine where COVID-19 occurs?

A new study provides information on the associations between weather parameters and seasonal coronavirus cases.

1 Nov 2021

Lehigh’s undergraduate students receive NIH Award for new sickle cell diagnostic device

Their tickets were booked. Their schedules were set. The students were finally going to test their product on real people. But in July, Sierra Leone's COVID-19 level spiked almost overnight, and Lehigh's Sickle Cell Anemia Diagnostic Device team lost yet another opportunity to conduct fieldwork.

1 Nov 2021

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

A cohort study found that antibodies to the SARS-CoV-2 spike protein and neutralizing antibodies remain relatively stable 8-11 months post-infection.

1 Nov 2021

Researchers identify an important mediator of thrombosis in CKD patients

Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be targeted for therapeutic purposes.

1 Nov 2021

Investigation of Budesonide's mechanism of action against SARS-CoV-2

Researchers look to gain an understanding of the mechanism of action of budesonide in improving the prognosis of patients with SARS-CoV-2 infection.

1 Nov 2021

Ethnic and socioeconomic disparities persist among U.S. adults who identify as disabled

A new analysis led by Johns Hopkins Medicine researchers finds that the number of U.S. adults who report they have a disability is 27%, representing 67 million adults, an increase of 1% since the data were last analyzed in 2016.

1 Nov 2021

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Scientists explore the link between SARS-CoV-2 infection and anti-NMDAR encephalitis.

1 Nov 2021

Smoking related to lower rates of BP control in hypertensive patients taking medicines

Smoking and high blood pressure are independent cardiovascular risk factors that frequently coexist within patients.

1 Nov 2021

Study: 7.4% of renal disease hospitalizations can be attributed to increase in temperature

Today the world's largest study of the impact of temperature changes and kidney disease reveals that 7.4 per cent of all hospitalizations for renal disease can be attributed to an increase in temperature. In Brazil – where the study was focused – this equated to more than 202,000 cases of kidney disease from 2000-2015.

1 Nov 2021

Study shows COVID vaccination highly protective against death, especially for older age groups

Researchers from the UK used EAVE II, an individual-level, national surveillance system, to determine the frequency of COVID-19-related fatalities among fully vaccinated individuals and to define the clinical and demographic characteristics of COVID-19 deaths in fully vaccinated individuals since the beginning of the COVID-19 vaccination program in Scotland.

1 Nov 2021

Large U.S. study finds majority of mRNA COVID-19 side effects are mild and temporary

A new study posted to the medRxiv* preprint server, analyzed safety data from over 298 million mRNA COVID-19 vaccines administered in the first six months after the U.S. began its vaccination campaign.

1 Nov 2021

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

Research published in the journal Nature Medicine suggests a risk for neurological complications after the first shot of a COVID-19 vaccine. However, the likelihood of developing neurological complications remains far greater among people infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

31 Oct 2021

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.

31 Oct 2021

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.

30 Oct 2021

Medical Condition News

UMass Amherst and Brigham launch MassAITC to improve in-home care for Alzheimer's patients

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

Platelet inhibitors may be linked with reduction in digital ulcers in people with systemic sclerosis

New findings can help identify people at increased risk of hydroxychloroquine-related retinopathy

Startup receives funding for developing a device to prevent epilepsy-related death

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

Do weather and climate determine where COVID-19 occurs?

Lehigh’s undergraduate students receive NIH Award for new sickle cell diagnostic device

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

Researchers identify an important mediator of thrombosis in CKD patients

Investigation of Budesonide's mechanism of action against SARS-CoV-2

Ethnic and socioeconomic disparities persist among U.S. adults who identify as disabled

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Smoking related to lower rates of BP control in hypertensive patients taking medicines

Study: 7.4% of renal disease hospitalizations can be attributed to increase in temperature

Study shows COVID vaccination highly protective against death, especially for older age groups

Large U.S. study finds majority of mRNA COVID-19 side effects are mild and temporary

Neurological complications are higher with SARS-CoV-2 infection than COVID vaccine, study finds

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

Stanford neuromodulation therapy causes remission in almost 80% of patients with severe depression

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News